Understanding Pharmacoepidemiology e-bog
504,55 DKK
(ekskl. moms 403,64 DKK)
A concise introduction to the study of medication utilization and safety in large populations of peopleUnderstanding Pharmacoepidemiology is a clear, engagingly written roadmap to mastering the important concepts and methods of pharmacoepidemiology. It explains what pharmacoepidemiology is, how pharmacoepidemiology studies are conducted, and how to interpret findings. You will learn the importanc…
E-bog
504,55 DKK
Forlag
McGraw Hill / Medical
Udgivet
2010-12-31
Længde
208 sider
Genrer
Medicine: general issues
Sprog
English
Format
epub
Beskyttelse
LCP
ISBN
9780071766678
A concise introduction to the study of medication utilization and safety in large populations of peopleUnderstanding Pharmacoepidemiology is a clear, engagingly written roadmap to mastering the important concepts and methods of pharmacoepidemiology. It explains what pharmacoepidemiology is, how pharmacoepidemiology studies are conducted, and how to interpret findings. You will learn the importance of pharmacoepidemiology, basic terminology used in research, and the data sources, study designs, and statistical analyses employed in pharmacoepidemiology research. Upon completing Understanding Pharmacoepidemiology you will have a better understanding of how to evaluate the associations between medication utilization and outcomes.Each chapter includes these valuable learning aids: A list of learning objectives Case studies or examplesDiscussion questionsTables and FiguresYou will also find a glossary of important words and terms. The content you need to understand the concepts and methods of pharmacoepidemiology:Introduction to Pharmacoepidemiology: Principles of Epidemiology Applied to the Study of Medication Use, Study Designs in Pharmacoepidemiology: Using Secondary Data in Pharmacoepidemiology; Biostatistics and Pharmacoepidemiology: Other Methodological Issues; Evaluation of Pharmacoepidemiology Literature; Medication Utilization Patterns; Medication Safety and Pharmacovigilance; and FDA Perspectives on Post-market Drug Safety.
Dansk